Recommendations for a public health approach - Second edition
Authors:
WHO
WHO
Overview
These guidelines provide guidance on the diagnosis of human immunodeficiency virus
(HIV) infection, the use of antiretroviral (ARV) drugs for treating and preventing HIV
infection and the care of people living with HIV. They are structured along the continuum
of HIV testing, prevention, treatment and care.
This edition updates the 2013 consolidated
guidelines on the use of
antiretroviral drugs following an extensive review of evidence and
consultations in
mid-2015, shared at the end of 2015, and now published in full in 2016.
It is being published in a changing global context for HIV and for
health more broadly.
The guidelines by chapter
- Executive summarypdf, 49kb
- Summary of recommendationspdf, 118kb
- Chapter 1 - Introductionpdf, 127kb
- Chapter 2 - Clinical guidelines: HIV diagnosispdf, 204kb
- Chapter 3 - Clinical guidelines: antiretroviral drugs for HIV preventionpdf, 148kb
- Chapter 4 - Clinical guidelines: antiretroviral therapypdf, 486kb
- Chapter 5 - Clinical guidelines: managing common coinfections and comorbiditiespdf, 276kb
- Chapter 6 - Service deliverypdf, 809kb
- Chapter 7 - Monitoring and evaluationpdf, 210kb
- Chapter 8 - Publication, dissemination and evaluationpdf, 68kb
- Annexespdf, 1.68Mb
Related links
-
Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV
September 2015 -
Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: what’s new
Policy brief - November 2015 - More about treatment and care
- HIV guidelines
- HIV policy briefs
Contact us
Read more articles here from WHO: http://www.who.int/hiv/en/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.